ReviewPharmaceuticals (Basel, Switzerland)2023

Safety of Immunomodulatory Systemic Therapies Used in the Management of Immune-Related Cutaneous Adverse Events.

Stephanie L Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.